DK1802635T3 - Heteroatomholdige tricykliske forbindelser - Google Patents

Heteroatomholdige tricykliske forbindelser

Info

Publication number
DK1802635T3
DK1802635T3 DK05793907.6T DK05793907T DK1802635T3 DK 1802635 T3 DK1802635 T3 DK 1802635T3 DK 05793907 T DK05793907 T DK 05793907T DK 1802635 T3 DK1802635 T3 DK 1802635T3
Authority
DK
Denmark
Prior art keywords
heteroatomic
tricyclic compounds
tricyclic
compounds
heteroatomic tricyclic
Prior art date
Application number
DK05793907.6T
Other languages
English (en)
Inventor
Maximilian Grassberger
Amarylla Horvath
Original Assignee
Meda Pharma S A R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0422643A external-priority patent/GB0422643D0/en
Priority claimed from GB0427599A external-priority patent/GB0427599D0/en
Application filed by Meda Pharma S A R L filed Critical Meda Pharma S A R L
Application granted granted Critical
Publication of DK1802635T3 publication Critical patent/DK1802635T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK05793907.6T 2004-10-12 2005-10-10 Heteroatomholdige tricykliske forbindelser DK1802635T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0422643A GB0422643D0 (en) 2004-10-12 2004-10-12 Organic compounds
GB0427599A GB0427599D0 (en) 2004-12-16 2004-12-16 Organic compounds
PCT/EP2005/010889 WO2006040111A2 (en) 2004-10-12 2005-10-10 Heteroatoms-containing tricyclic compounds

Publications (1)

Publication Number Publication Date
DK1802635T3 true DK1802635T3 (da) 2012-09-10

Family

ID=36084355

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05793907.6T DK1802635T3 (da) 2004-10-12 2005-10-10 Heteroatomholdige tricykliske forbindelser

Country Status (28)

Country Link
US (1) US7514554B2 (da)
EP (1) EP1802635B8 (da)
JP (1) JP5032326B2 (da)
KR (1) KR101228188B1 (da)
CN (1) CN101031573B (da)
AR (1) AR051386A1 (da)
AU (1) AU2005293799B2 (da)
BR (1) BRPI0516873A (da)
CA (1) CA2581046C (da)
DK (1) DK1802635T3 (da)
EC (1) ECSP077384A (da)
ES (1) ES2389206T3 (da)
GT (1) GT200500282A (da)
HK (1) HK1105634A1 (da)
IL (1) IL182307A (da)
JO (1) JO2727B1 (da)
MA (1) MA28932B1 (da)
MX (1) MX2007004258A (da)
MY (1) MY140880A (da)
NO (1) NO338603B1 (da)
NZ (1) NZ554010A (da)
PE (1) PE20060581A1 (da)
PL (1) PL1802635T3 (da)
PT (1) PT1802635E (da)
RU (1) RU2394037C2 (da)
TN (1) TNSN07133A1 (da)
TW (1) TWI361192B (da)
WO (1) WO2006040111A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006060616A1 (en) * 2004-12-01 2006-06-08 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Processes for producing crystalline macrolides
IT1394309B1 (it) 2009-05-22 2012-06-06 Poli Ind Chimica Spa Nuovo approccio chimico-enzimatico alla sintesi del pimecrolimus
CN106854228B (zh) * 2015-12-08 2020-05-29 博瑞生物医药（苏州）股份有限公司 一种吡美莫司的制备方法
EP3178824A1 (en) 2015-12-08 2017-06-14 Medichem, S.A. Process for preparing pimecrolimus
EP3619215B1 (en) * 2017-05-01 2021-11-17 MEDA Pharma GmbH & Co. KG Process to convert crude ascomycin into purified pimecrolimus

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464366A (en) * 1979-12-19 1984-08-07 Ciba Geigy Corporation Cephem compounds having a terminal aminocarboxylic acid grouping and containing an azacyclyl(thio)ureido group
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
DK0427680T3 (da) * 1989-11-09 1995-12-18 Sandoz Ltd Heteroatom-holdige cykliske forbindelser
US5352671A (en) * 1989-11-09 1994-10-04 Sandoz Ltd. Heteroatoms-containing tricyclic compounds
EP0480623A1 (en) 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity
MY110603A (en) 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
US6160117A (en) * 1997-11-06 2000-12-12 Zeneca Limited Chemical process
GB0012383D0 (en) * 2000-05-22 2000-07-12 Novartis Ag Organic compounds
US6667312B2 (en) * 2000-12-08 2003-12-23 3M Innovative Properties Company Thioether substituted imidazoquinolines

Also Published As

Publication number Publication date
CA2581046A1 (en) 2006-04-20
KR101228188B1 (ko) 2013-01-30
EP1802635A2 (en) 2007-07-04
PL1802635T3 (pl) 2013-07-31
BRPI0516873A (pt) 2008-09-23
CN101031573B (zh) 2010-06-09
AU2005293799B2 (en) 2009-02-26
NO20072127L (no) 2007-06-08
NO338603B1 (no) 2016-09-12
EP1802635B8 (en) 2013-04-17
JP5032326B2 (ja) 2012-09-26
CN101031573A (zh) 2007-09-05
PE20060581A1 (es) 2006-08-17
RU2007117497A (ru) 2008-11-20
MX2007004258A (es) 2007-05-11
ES2389206T3 (es) 2012-10-24
CA2581046C (en) 2013-03-26
TW200626603A (en) 2006-08-01
MY140880A (en) 2010-01-29
EP1802635B1 (en) 2012-06-06
RU2394037C2 (ru) 2010-07-10
WO2006040111A3 (en) 2006-06-22
TWI361192B (en) 2012-04-01
US7514554B2 (en) 2009-04-07
TNSN07133A1 (en) 2008-11-21
IL182307A (en) 2011-06-30
NZ554010A (en) 2009-10-30
AR051386A1 (es) 2007-01-10
WO2006040111A2 (en) 2006-04-20
ECSP077384A (es) 2007-05-30
MA28932B1 (fr) 2007-10-01
GT200500282A (es) 2006-05-04
KR20070063535A (ko) 2007-06-19
PT1802635E (pt) 2012-08-21
AU2005293799A1 (en) 2006-04-20
US20080071082A1 (en) 2008-03-20
HK1105634A1 (en) 2008-02-22
JP2008515945A (ja) 2008-05-15
JO2727B1 (en) 2013-09-15
IL182307A0 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
ATE442044T1 (de) Herbizid-safener-kombination
ATE404546T1 (de) Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen
ATE490251T1 (de) Tricyclische opioidmodulatoren
ATE387440T1 (de) Neue 4-benzylidenpiperidinderivate
DK1812448T3 (da) Organiske forbindelser
DE602005017191D1 (de) Geruchsreduzierte waschstück-zusammensetzung
ATE425167T1 (de) Neue pyridothienopyrimidinderivate
DE602005023145D1 (de) Neue androgene
DE602005008596D1 (de) Neue tetracyclische tetrahydrofuranderivate
DK1802635T3 (da) Heteroatomholdige tricykliske forbindelser
DE502005003827D1 (de) Zahnrad
FI20041698A (fi) Lukko
DE602005002751D1 (de) Substituierte tricyclische benzimidazole
DE502005006235D1 (de) Zahnradanordnung
FR2871686B1 (fr) Composition anti-decoloration
ATE384719T1 (de) Dioxazinyl-substituierte thienylsulfonylaminocarbonylverbindungen
SE0400022D0 (sv) New compounds
SE0402103D0 (sv) Novel compounds
FR2874034B3 (fr) Pavage
FI20041369A (fi) Yhdistetyt hanat
SE0400254D0 (sv) New compounds
SE0402391D0 (sv) Novelheterocyclic compounds
DOP2004000959A (es) Compuestos
UA10538S (uk) Басейн
SE0400227D0 (sv) New compounds